Technologieangebote

Operationen bei Herz- oder Gefäßmissbildungen erfordern

oft den Einsatz von Herz-Lungen-Maschinen (HLM). Diese
…

Operationen bei Herz- oder Gefäßmissbildungen erfordern

oft den Einsatz von Herz-Lungen-Maschinen (HLM). Diese
…

Die Erzeugung von Protonen über die Bestrahlung dünner

Folien durch extreme kurze Laserpulse (laser-driven

proton beams), hat kürzlich enorme…

Scientists at the Georg-August-University generated monoclonal antibodies which specifically react with beta2-adrenergic receptor (b2AR) on human leukocytes and other cells with physiological expression levels of this receptor. b2AR is a prototypic G protein coupled receptor which is activated by catecholamines. It fulfills important roles in the regulation of several organ systems and coordinates functions of the endocrine, neurological and immune system. b2AR mediate glycogenolysis/gluconeogenesis in liver and relaxation of smooth muscle and are important drug targets for a wide variety of cardiovascular, respiratory and other deseases.

Scientists at the University of Göttingen generated polyklonal and monoclonal antibodies against the new diagnostic tumor marker PIWIL2. The tumor marker PIWIL2 is not present in normal cells (other than testicular), not present in inflammtory tissues but present in almost all cancer cell types. Because of its important role in tumor genesis and therefor early detection of tumors it could be used for first line screening. Monoclonal antibodies against PIWIL2 could be used for tissue analysis in surgery in clinics, detection of PIWIL2 in blood samples (ELISA) and monitoring of reponse to cancer treatment. Furthermore the antibodies could be used for targeting PIWIL2 within a cancer therapy.

Die vorliegende Erfindung stellt erstmals hydrolytisch abbaubare, ionische Copolymere bereit, die durch radikalische Polymerisation hergestellt werden und je…